Ashok C. Chander, PhD

Ashok C. Chander, PhD has a diverse background in the biotechnology industry, with over 12 years of senior executive experience. Ashok C. has held various roles at Cellanyx, including CEO & CTO, CTO, and Board Member. In these positions, they were responsible for managing company operations, fundraising, and transitioning the company's scope. Ashok C. currently serves as an investor representative acting Executive Chairman.

Additionally, Ashok has experience as the President of SymetryML, where they developed and executed a strategy for pivoting a fintech AI platform to three healthcare verticals. Ashok C. also worked as a Biotech Management Consultant at Stealth Mode Biotech.

Before their industry roles, Ashok obtained a PhD from Columbia University, where they conducted research on cell and tissue behavior, focusing on extra-cellular matrix (ECM) sensing, rigidity sensing, force generation, migration, growth, and proliferation. Ashok C. developed expertise in bio-engineering, oncology, tissue engineering, nanomedicine, and mechanobiology.

Furthermore, Ashok has experience as a Science Technology Fellow at Columbia Technology Ventures, conducting market research on emerging technologies. Ashok C. also co-founded Imfuse, where they led a team to develop a natural language processing (NLP) product and designed an instant messaging-based CRM toolkit.

Earlier in their career, Ashok served as a Principal Investigator at the Massachusetts Institute of Technology (MIT), where they secured funding and directed a team to build an information technology (IT) system. Ashok C. also worked as a Research Associate at Dartmouth College and a Research Assistant at the NIH.

Overall, Ashok C. Chander, PhD has extensive experience in biotechnology, leadership, research, technology development, and market analysis.

Ashok C. Chander, PhD completed their undergraduate studies in Biology and obtained a Bachelor of Science (B.S.) degree from the Massachusetts Institute of Technology. Later, they pursued further education in the Biological Sciences and earned a Doctor of Philosophy (PhD) degree from Columbia University.